tradingkey.logo

Exact Sciences Corp

EXAS
View Detailed Chart

46.800USD

-0.740-1.56%
Close 07/30, 16:00ETQuotes delayed by 15 min
8.83BMarket Cap
LossP/E TTM

Exact Sciences Corp

46.800

-0.740-1.56%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.56%

5 Days

-3.33%

1 Month

-11.93%

6 Months

-16.47%

Year to Date

-16.71%

1 Year

+0.47%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 27 analysts
BUY
Current Rating
69.005
Target Price
45.15%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

553
Total
5
Median
6
Average
Company name
Ratings
Analysts
Exact Sciences Corp
EXAS
27
CRISPR Therapeutics AG
CRSP
29
Intellia Therapeutics Inc
NTLA
28
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
argenx SE
ARGX
25
1
2
3
...
111

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(9)
Neutral(1)
Buy(0)
Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.964
Sell
RSI(14)
34.428
Neutral
STOCH(KDJ)(9,3,3)
4.619
Oversold
ATR(14)
1.851
Low Volatility
CCI(14)
-105.493
Sell
Williams %R
97.932
Oversold
TRIX(12,20)
-0.427
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
47.928
Sell
MA10
48.891
Sell
MA20
51.183
Sell
MA50
53.334
Sell
MA100
49.957
Sell
MA200
53.866
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.
Ticker SymbolEXAS
CompanyExact Sciences Corp
CEOMr. Kevin T. Conroy
Websitehttps://www.exactsciences.com/
KeyAI